Early apoptosis of monocytes induced by Helicobacter pylori infection through multiple pathways

Ying Zhang1, Hui Sun1, Huilin Zhao1

  • 1School of Basic Medical Sciences, Binzhou Medical University, Yantai, 264003, China.

Insights

Helicobacter pylori (H. pylori) infection induces early monocyte apoptosis, a mechanism for immune evasion. This study reveals how H. pylori manipulates cell death pathways, potentially explaining why few infected individuals develop gastric disease.

Area of Science:

  • Immunology
  • Cell Biology
  • Microbiology

Background:

  • Helicobacter pylori (H. pylori) infection is common, but only a small fraction of infected individuals develop chronic gastric diseases.
  • The precise pathological mechanisms underlying H. pylori-induced gastric pathology remain incompletely understood.
  • Investigating H. pylori's interaction with immune cells, specifically monocytes, is crucial for understanding disease development.

Purpose of the Study:

  • To elucidate the pathological mechanisms of H. pylori infection by examining its effect on monocyte apoptosis.
  • To identify the specific molecular pathways involved in H. pylori-induced monocyte apoptosis.
  • To explore potential reasons for the low incidence of H. pylori-related gastric diseases.

Main Methods:

  • Co-culturing H. pylori with human peripheral blood monocytes, THP-1, and U937 cell lines.
  • Assessing early and late apoptosis at 6, 12, and 24 hours post-infection using flow cytometry and molecular markers.
  • Analyzing the expression levels of key apoptosis-related proteins, including phosphorylated Bad, JNK, Bcl-2, and Akt, as well as activated caspases.

Main Results:

  • H. pylori infection induced early apoptosis in peripheral blood monocytes, THP-1, and U937 cells at various time points.
  • Infection led to increased phosphorylated Bad and JNK, and decreased Bcl-2 in peripheral blood monocytes.
  • H. pylori modulated apoptotic pathways differently across cell types, involving Akt in early stages and Bad, Bcl-2, caspases, and JNK in later stages in THP-1 cells, while primarily Bad and JNK in U937 cells.

Conclusions:

  • H. pylori employs a novel immune evasion strategy by upregulating early monocyte apoptosis and inhibiting late apoptosis.
  • Differential apoptotic responses among monocyte cell types may explain the low prevalence of H. pylori-associated gastric diseases.
  • Understanding these mechanisms provides a basis for developing targeted therapies for H. pylori-derived gastric conditions.

Related Concept Videos

Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.4K
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy01:16

Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy

Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
1.7K
Gastritis-II: Pathophysiology01:17

Gastritis-II: Pathophysiology

Gastritis is marked by disruption of the mucosal barrier that usually protects the stomach tissue from digestive juices and manifests in acute and chronic forms.
In acute gastritis, the gastric mucosa becomes swollen and red and undergoes superficial erosion. Superficial ulceration may lead to bleeding.
In chronic gastritis, persistent or repeated insults lead to chronic inflammatory changes and, eventually, thinning or atrophy of the gastric tissue.
Gastritis can stem from various causes, each...
1.5K
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors01:24

Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors

Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI)  tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.4K
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.4K
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
959